Coronary interventions

Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system

EuroIntervention 2015;11:860-867. DOI: 10.4244/EIJV11I8A176

Stefan Verheye
Stefan Verheye1*, MD, PhD; Ian Buysschaert2, MD, PhD; Eberhard Grube3, MD, PhD
1. Antwerp Cardiovascular Center, ZNA Middelheim, Antwerp, Belgium;2. ASZ Aalst, Aalst, Belgium; 3. Heart Center, Siegburg, Germany

Aims: Our aim was to evaluate the five-year clinical impact of side branch (SB) stenting with a drug-eluting stent (DES) following Axxess stent implantation in coronary bifurcation lesion

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

axxess stentbifurcation lesionbiolimus a9coronary artery diseaseclinical researchside branch
Read next article
DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial

Latest news